Eledon Pharmaceuticals, Inc.
ELDN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001404281
No open-market purchases or sales by Eledon Pharmaceuticals, Inc. insiders were filed in the last 90 days; 161 institutions reported holding it in 13F filings for Q2 2026, worth $184.6M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Eledon Pharmaceuticals, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 31 | 31 | 0 |
| Shares | 6.54M | 6.27M | −266.8K (−4.1%) |
| Value | $15.9M | $17.3M | +$1.35M (+8.5%) |
New holders (2)
Institutions that held Eledon Pharmaceuticals, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Dimensional Fund Advisors LP | 17,950 | $50.0K | 0.00% |
| Royal Bank of Canada | 38 | $0 | 0.00% |
Sold out (2)
Institutions that held Eledon Pharmaceuticals, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Bailard, Inc. | 27,413 | $67.0K |
| Simplex Trading, LLC | 287 | $0 |